The role of c-Met and VEGFR2 in glioblastoma resistance to bevacizumab

Dismal prognosis of glioblastoma (GBM) prompts for the identification of response predictors and therapeutic resistance mechanisms of current therapies. The authors investigated the impact of c-Met, HGF, VEGFR2 expression and microvessel density (MVD) in GBM patients submitted to second-line chemoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Carvalho, Bruno, Lopes, José Manuel, Silva, Roberto, Peixoto, Joana, Leitão, Dina, Soares, Paula, Fernandes, Ana Catarina, Linhares, Paulo, Vaz, Rui, Lima, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966794/
https://www.ncbi.nlm.nih.gov/pubmed/33727583
http://dx.doi.org/10.1038/s41598-021-85385-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966794/
https://www.ncbi.nlm.nih.gov/pubmed/33727583
http://dx.doi.org/10.1038/s41598-021-85385-1

Ejemplares similares